Drug Shortage Report for NOZINAN INJ 25MG/ML

Last updated on 2020-08-07 History
Report ID 120468
Drug Identification Number 01927698
Brand name NOZINAN INJ 25MG/ML
Common or Proper name Nozinan inj 25mg/mL
Company Name SANOFI-AVENTIS CANADA INC
Market Status MARKETED
Active Ingredient(s) METHOTRIMEPRAZINE
Strength(s) 25MG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS
Packaging size 10 amps
ATC code N05AA
ATC description ANTIPSYCHOTICS
Reason for shortage Other (Please describe in comments)
Anticipated start date 2020-08-10
Actual start date
Estimated end date 2020-08-21
Actual end date 2020-08-07
Shortage status Avoided shortage
Updated date 2020-08-07
Company comments Product on allocation. Production delay. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. Patients should validate the availability of the product with their respective pharmacy.
Health Canada comments
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2020-07-16 English Compare
v2 2020-07-16 French Compare
v3 2020-07-16 English Compare
v4 2020-07-16 French Compare
v5 2020-07-21 English Compare
v6 2020-07-21 French Compare
v7 2020-08-07 English Compare